Cargando…

Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-β(1) as compared with healthy nasal mucosa

OBJECTIVE: To evaluate TGF-β(1) expression in polypoid mucosa (epithelium and stroma) of patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). METHODS: Cross-sectional study with two groups: 17 patients with nasal polyposis and 11 controls. Polyps and normal nasal mucosa were processed...

Descripción completa

Detalles Bibliográficos
Autores principales: Balsalobre, Leonardo, Pezato, Rogério, Perez-Novo, Claudina, Alves, Maria Teresa S, Santos, Rodrigo P, Bachert, Claus, Weckx, Luc LM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651223/
https://www.ncbi.nlm.nih.gov/pubmed/23663486
http://dx.doi.org/10.1186/1916-0216-42-29
Descripción
Sumario:OBJECTIVE: To evaluate TGF-β(1) expression in polypoid mucosa (epithelium and stroma) of patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). METHODS: Cross-sectional study with two groups: 17 patients with nasal polyposis and 11 controls. Polyps and normal nasal mucosa were processed by immunohistochemical methods for TGF-β1 visualization. Then, the percentage of TGF-β1 expression in stroma and epithelium was objectively quantified using UT Morph software. RESULTS: A lower percentage of positive expression was found in the epithelium of CRSwNP patients (32.44%) versus normal controls (55.91%) (p < 0.05), and a higher percentage of positive expression in the stroma of CRSwNP patients (23.24%) versus controls (5.88%) (p < 0.05). CONCLUSION: The lower percentage of TGF-β(1) expression in the nasal epithelium of CRSwNP patients may have an impact on epithelium-directed topical treatments employed in this patient population.